BCG therapy for bladder cancer

سال انتشار: 1397
نوع سند: مقاله کنفرانسی
زبان: انگلیسی
مشاهده: 557

نسخه کامل این مقاله ارائه نشده است و در دسترس نمی باشد

این مقاله در بخشهای موضوعی زیر دسته بندی شده است:

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

MBMED05_023

تاریخ نمایه سازی: 1 دی 1397

چکیده مقاله:

Background: BCG therapy is used as a treatment in bladder cancer. Methods: Intravesical administration of Bacillus Calmette-Guérin is used as a treatment method in superficial bladder cancer. While it is commonly effective, some serious side effects may occur. We hereby report a 65-year-old man who developed granulomatous hepatitis as a complication following BCG therapy. Results and Conclution: He was treated successfully with antitubercular therapy and prednisolone.

نویسندگان

Mohsen Ayati

Uro-Oncology Research Center, Tehran University of Medical Sciences, Tehran, Iran

Mohammad Reza Nowroozi

Uro-Oncology Research Center, Tehran University of Medical Sciences, Tehran, Iran

Afshin Mortazavi

Uro-Oncology Research Center, Tehran University of Medical Sciences, Tehran, Iran

Solmaz Ohadian Moghadam

Uro-Oncology Research Center, Tehran University of Medical Sciences, Tehran, Iran